RESORBA® Synthetic Bone | 2 syringes of 0.5 cc

RESORBA® Synthetic Bone is a fully synthetic bone graft substitute developed using MBCP® (Biphasic Calcium Phosphate) technology. Its composition of 20% hydroxyapatite (HA) and 80% beta-tricalcium phosphate (β-TCP) provides an optimal balance between graft stability and progressive bone remodeling, allowing the biomaterial to be gradually replaced by newly formed bone.

Manufactured by RESORBA®, a German company with extensive experience in biomaterials for oral surgery, this synthetic graft offers excellent biocompatibility and osteoconductive properties to support bone regeneration in a wide range of surgical procedures.

Its 0.5–1.0 mm particle size ensures excellent handling characteristics and homogeneous adaptation to the bone defect.

Clinical Benefits

• Fully synthetic bone graft substitute.
• MBCP® Biphasic Calcium Phosphate technology.
• Excellent osteoconductive properties.
• Promotes predictable bone regeneration and remodeling.
• High biocompatibility.
• Easy handling and placement.
• Uniform particle size of 0.5–1.0 mm.

Indications

• Alveolar ridge preservation following tooth extraction.
• Guided Bone Regeneration (GBR).
• Bone augmentation procedures.
• Peri-implant bone defects.
• Periodontal bone defects.
• Oral surgery.
• Implant dentistry.
• Maxillofacial surgery.

Composition

• MBCP® (Biphasic Calcium Phosphate) technology.
• 20% Hydroxyapatite (HA).
• 80% Beta-Tricalcium Phosphate (β-TCP).

Packaging

• Reference: SB0701M+GS01.
• Particle size: 0.5–1.0 mm.
• Contents: 2 syringes of 0.5 cc.